Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fadela Bouafia"'
Autor:
Delphine Maucort-Boulch, Emmanuel Bachy, Alexandra Traverse Glehen, Violaine Safar, Estelle Bourbon, Dana Ghergus, Lionel Karlin, Clémentine Sarkozy, Lauriane Filliatre-clement, Emmanuelle Ferrant, Anne Lazareth, Gilles Salles, Fadela Bouafia, Herve Ghesquieres, Pierre Sesques, Bertrand Coiffier
Publikováno v:
Hematological Oncology. 36:533-542
In the rituximab era, one-third of diffuse large B-cell lymphoma patients experience relapse/refractory disease after first-line anthracycline-based immunochemotherapy. Optimal management remains an unmet medical need. The aim of this study was to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ebbf878af2e99235db4fe59a109e69b
https://doi.org/10.1002/hon.2512
https://doi.org/10.1002/hon.2512
Autor:
Bertrand Coiffier, Catherine Thieblemont, Gilles Salles, Olivier Hequet, Jocelyne Drai, Daniel Espinouse, Charles Dumontet, Fadela Bouafia
Publikováno v:
British Journal of Haematology. 112:405-409
Patients receiving high-dose cyclophosphamide as a conditioning regimen for peripheral stem cell collection are subjected over a short period of time to significant exposure to reactive oxygen species (ROS). All these patients undergo profound leucop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ea7c67df67da6d6710ab1c386c68852
https://doi.org/10.1046/j.1365-2141.2001.02595.x
https://doi.org/10.1046/j.1365-2141.2001.02595.x
Autor:
Fadela Bouafia, Franck Morschhauser, Pier Luigi Zinzani, Lisette Sloots, Charles Dumontet, Michael A. Burgess
A phase I/II trial was performed to investigate the safety and tolerance of zosuquidar.3HCL, a potent inhibitor of P-glycoprotein (P-gp), when administered orally alone and in combination with the CHOP regimen in patients with untreated non-Hodgkin's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa228bf345db5148fd5646159ebacc7
http://hdl.handle.net/11585/51399
http://hdl.handle.net/11585/51399
Autor:
Fadela, Bouafia, Jocelyne, Drai, Jacques, Bienvenu, Catherine, Thieblemont, Daniel, Espinouse, Gilles, Salles, Bertrand, Coiffier
Publikováno v:
Bulletin du cancer. 91(7-8)
Serum lacticodehydrogenase (LDH) is commonly increased in patients with haematopoietic malignancies and has been shown to be a prognostic factor in patients with non-Hodgkin's lymphoma (NHL) and myeloma. We have examined the LDH isoenzyme content in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c069420aef2576574e63be89c19274c
https://pubmed.ncbi.nlm.nih.gov/15381461
https://pubmed.ncbi.nlm.nih.gov/15381461
Autor:
Fadela Bouafia, D. Guyotat, E. Berger, C. Ardiet, B. Tranchand, Catherine Sebban, C. Dumontet, Jérôme Jaubert, Catherine Lucas, B. Coiffier
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 14(4)
Background: Patients with relapsing or refractory multiple myeloma have poor prognosis. Few compounds are active in these patients and response duration remains short. We report the results of an open phase II trial evaluating the efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4760861a681c70c5daf79bada2cd6a7
https://pubmed.ncbi.nlm.nih.gov/12649110
https://pubmed.ncbi.nlm.nih.gov/12649110
Autor:
Gilles Salles, Fadela Bouafia, Nicolas Ketterer, I Moullet, E.-M. Neidhart-Berard, C. Dumontet, Catherine Thieblemont, Pascale Felman, B. Coiffier
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(10)
Summary Objectives: Retrospective evaluation of anemia frequency and its prognostic value in patients with different subtypes of nonHodgkin's lymphoma and comparison with other clinical characteristics. Patients and methods: Anemia was defined as a h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66314fd3c9b0445d380dd124402c1b7a
https://pubmed.ncbi.nlm.nih.gov/9834824
https://pubmed.ncbi.nlm.nih.gov/9834824
Autor:
N Ketterer, Evelyne Callet-Bauchu, I Moullet, Charles Dumontet, Gilles Salles, Fadela Bouafia, Pascale Felman, Catherine Thieblemont, H Samaha, Bertrand Coiffier, Françoise Berger
Publikováno v:
Leukemia. 12(8)
Mantle cell lymphoma (MCL) patients represent a difficult prob-lem, sometimes to establish the diagnosis but mostly becauseof their refractoriness to standard lymphoma treatments. Whichtreatments to apply and to whom is not yet defined. In thisstud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3590d6dfea71802d281a7e1965af44d7
https://pubmed.ncbi.nlm.nih.gov/9697885
https://pubmed.ncbi.nlm.nih.gov/9697885
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma
Autor:
Nicolas Ketterer, Fadela Bouafia, E. M. Neidhardt-Berard, Gilles Salles, I Moullet, D. Espinouse, Françoise Berger, C. Dumontet, B. Coiffier, Pascale Felman
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 8(7)
Summary Background: Despite improved detection of mantle cell lymphoma (MCL), results of its treatment with conventional therapies remain disappointing and the survival rate poor. The role of high-dose chemotherapy has recently been investigated but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09eb98b7c8c75f2a327d6a353e294748
https://pubmed.ncbi.nlm.nih.gov/9296227
https://pubmed.ncbi.nlm.nih.gov/9296227